IP Library Granted Patent US 11,459,610
Granted Patent B2
US 11,459,610 · App. 15/960,035 · Granted Oct 4, 2022

Compositions and methods for improving sample identification in indexed nucleic acid libraries

Inventors: Michael Chesney (Nr Saffron Walden, GB); Vincent Peter Smith (Nr Saffron Walden, GB); Claire Bevis-Mott (Nr Saffrom Walden, GB); Jonathan Mark Boutell (Nr Saffron Walden, GB); Angela Kalbande (Nr Saffron Walden, GB)
Assignee: ILLUMINA CAMBRIDGE LIMITED
C12Q1/6874C12N15/1065C12Q1/6806C12Q1/6809C12Q1/6816C12Q1/6834C12Q1/6855C40B40/06C40B20/04C40B50/16C40B50/18C40B70/00C40B80/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,459,610
App. No.
15/960,035
Granted
Oct 4, 2022
Kind
B2
Abstract

The present invention is concerned with compositions and methods for improving the rate of correct sample identification in indexed nucleic acid library preparations for multiplex next generation sequencing by exonuclease treatment and optionally blocking the 3′ ends of pooled indexed polynucleotides from multiple samples prior to amplification and sequencing.

Claims (68)

1. A composition comprising:

a first plurality of adapter-target-adapter molecules comprising double-stranded target fragments isolated from a first source,

wherein the adapter comprises a first sample-specific universal adapter,

wherein the first sample-specific universal adapter comprises

(i) a region of double stranded nucleic acid, and

(ii) a region of single-stranded non-complementary nucleic acid strands comprising at least one universal primer binding site,

wherein the first sample-specific universal adapter further comprises a first set of sample-specific tag sequences that differentiates the first plurality of adapter-target-adapter molecules from adapter-target-adapter molecules originating from a different source, the first set of sample-specific tag sequences present in the single stranded non-complementary nucleic acid strands, and

an exonuclease, wherein the exonuclease does not comprise a DNA polymerase activity.

2. The composition of claim 1 , further comprising first sample-specific universal adapters not attached to a target fragment.

3. The composition of claim 1 , wherein the exonuclease comprises a 5′ to 3′ DNA exonuclease activity that is biased for double stranded DNA that comprises a 5′ phosphate at the 5′ end of the region of double stranded nucleic acid.

4. The composition of claim 3 , wherein the exonuclease is lambda exonuclease.

5. The composition of claim 1 , wherein the exonuclease comprises a 3′ to 5′ DNA exonuclease activity that is biased for double stranded DNA that is blunt ended and/or has a recessed 3′ terminus.

6. The composition of claim 1 , the composition further comprising a second plurality of adapter-target-adapter molecules comprising double-stranded target fragments isolated from a second source,

wherein the adapter comprises a second sample-specific universal adapter that comprises a second set of sample-specific tag sequences that differentiates the first and second pluralities of adapter-target-adapter molecules.

7. The composition of claim 6 , wherein 3′ ends of the first and second pluralities of adapter-target-adapter molecules, or a combination thereof, are blocked.

8. The composition of claim 2 , wherein 3′ ends of the first sample-specific universal adapters not attached to a target fragment are blocked.

9. The composition of claim 1 , further comprising terminal deoxynucleotidyl transferase, a ddNTP, a DNA polymerase, or a combination thereof.

10. A method, comprising:

providing a first solution of a plurality of double-stranded target fragments isolated from a first source;

ligating a first sample-specific universal adapter to both ends of the double-stranded target fragments from the first source to form a first plurality of adapter-target-adapter molecules,

wherein each of the first plurality of adapter-target-adapter molecules comprises a target fragment flanked by the first sample-specific universal adapter,

wherein the first sample-specific universal adapter comprises (i) a region of double stranded nucleic acid, and (ii) a region of single-stranded non-complementary nucleic acid strands comprising at least one universal primer binding site,

wherein the first sample-specific universal adapter further comprises a first set of sample-specific tag sequences that differentiates the first plurality of adapter-target- adapter molecules from adapter-target-adapter molecules originating from a different source, the first set of sample-specific tag sequences present in the single stranded non-complementary nucleic acid strands, and

wherein the ligating covalently attaches the region of double stranded nucleic acid of the first sample-specific universal adapter to each end of the double-stranded target fragments from the first source; and

contacting the solution with an exonuclease, wherein the exonuclease comprises a 5′ to 3′ DNA exonuclease activity that is biased for double stranded DNA, wherein the exonuclease does not comprise a DNA polymerase activity,

wherein the exonuclease selectively degrades first sample-specific universal adapters present in the first solution not ligated to a target fragment.

11. The method of claim 10 , wherein the exonuclease comprises a 5′ to 3′ DNA exonuclease activity that is biased for double stranded DNA that comprises a 5′ phosphate at the 5′ end of the region of double stranded nucleic acid.

12. The method of claim 11 , wherein the exonuclease is lambda exonuclease.

13. The method of claim 10 , further comprising:

providing a second solution of a plurality of double-stranded target fragments isolated from a second source;

ligating a second sample-specific universal adapter to both ends of the double-stranded target fragments from the second source to form a second plurality of adapter-target-adapter molecules,

wherein each of the second plurality of adapter-target-adapter molecules comprises a target fragment from the second source flanked by the second sample-specific universal adapter,

wherein the second sample-specific universal adapter comprises (i) a region of double stranded nucleic acid, and (ii) a region of single-stranded non-complementary nucleic acid strands comprising at least one universal primer binding site,

wherein the second sample-specific universal adapter further comprises a second set of sample-specific tag sequences that differentiates the second plurality of adapter-target-adapter molecules from adapter-target-adapter molecules originating from a different source, the second set of sample-specific tag sequences present in the single stranded non-complementary nucleic acid strands, and

wherein the ligating covalently attaches the region of double stranded nucleic acid of the second sample-specific universal adapter to each end of the double-stranded target fragments from the second source; and

contacting the solution with an exonuclease, wherein the exonuclease comprises a 5′ to 3′ DNA exonuclease activity that is biased for double stranded DNA,

wherein the exonuclease selectively degrades second sample-specific universal adapters present in the second solution not ligated to a target fragment.

14. The method of claim 13 , further comprising blocking 3 ′ ends of the first and second pluralities of adapter-target-adapter molecules.

15. The method of claim 14 , wherein the blocking comprises enzymatically incorporating a dideoxynucleotide onto the 3′ ends of the first and second pluralities of adapter-target-adapter molecules and the 3′ ends of the first and second sample-specific universal adapters that are not attached to a target fragment.

16. The method of claim 13 , further comprising:

providing a surface comprising a plurality of amplification sites,

wherein the amplification sites comprise at least two populations of attached single stranded nuclei acids having a free 3′ end, and

contacting the surface comprising amplification sites with a mixture of the first and second pluralities of adapter-target-adapter molecules under conditions suitable to produce a plurality of amplification sites that each comprise a clonal population of amplicons from an individual adapter-target-adapter molecule.

17. A method, comprising:

providing a first solution of a plurality of double-stranded target fragments isolated from a first source;

ligating a first sample-specific universal adapter to both ends of the double-stranded target fragments from the first source to form a first plurality of adapter-target-adapter molecules,

wherein each of the first plurality of adapter-target-adapter molecules comprises a target fragment flanked by the first sample-specific universal adapter, wherein the first sample-specific universal adapter comprises (i) a region of double stranded nucleic acid, and (ii) a region of single-stranded non-complementary nucleic acid strands comprising at least one universal primer binding site,

wherein the first sample-specific universal adapter further comprises a first set of sample-specific tag sequences that differentiates the first plurality of adapter-target-adapter molecules from adapter-target-adapter molecules originating from a different source, the first set of sample-specific tag sequences present in the single stranded non-complementary nucleic acid strands, and

wherein the ligating covalently attaches the region of double stranded nucleic acid of the first sample-specific universal adapter to each end of the double-stranded target fragments from the first source; and

contacting the solution with an exonuclease, wherein the exonuclease comprises a 3′ to 5′ exonuclease activity that is biased for double stranded DNA having a blunt or recessed 3′ terminus, wherein the exonuclease does not comprise a DNA polymerase activity,

wherein the ligating also forms a plurality of incomplete products comprising adapter-target molecules, and wherein the exonuclease selectively degrades adapter-target molecules and first sample-specific universal adapters present in the first solution not ligated to a target fragment.

18. The method of claim 17 , wherein the exonuclease is exonuclease III.

19. The method of claim 17 , wherein the region of double stranded nucleic acid distal to the region of single-stranded non-complementary nucleic acid strands terminates as a blunt end structure.

20. The method of claim 19 , wherein the double-stranded target fragments comprise blunt end structures.

21. The method of claim 17 , wherein the region of double stranded nucleic acid distal to the region of single-stranded non-complementary nucleic acid strands terminates as a 3′ overhang structure.

22. The method of claim 17 , further comprising:

providing a second solution of a plurality of double-stranded target fragments isolated from a second source;

ligating a second sample-specific universal adapter to both ends of the double-stranded target fragments from the second source to form a second plurality of adapter-target-adapter molecules,

wherein each of the second plurality of adapter-target-adapter molecules comprises a target fragment from the second source flanked by the second sample-specific universal adapter,

wherein the second sample-specific universal adapter comprises (i) a region of double stranded nucleic acid, and (ii) a region of single-stranded non-complementary nucleic acid strands comprising at least one universal primer binding site,

wherein the second sample-specific universal adapter further comprises a second set of sample-specific tag sequences that differentiates the second plurality of adapter-target-adapter molecules from adapter-target-adapter molecules originating from a different source, the second set of sample-specific tag sequences present in the single stranded non-complementary nucleic acid strands, and

wherein the ligating covalently attaches the region of double stranded nucleic acid of the second sample-specific universal adapter to each end of the double-stranded target fragments from the second source; and

contacting the solution with an exonuclease, wherein the exonuclease comprises a 3′ to 5′ exonuclease activity that is biased for double stranded DNA having a blunt or 3′ recessed terminus, wherein the exonuclease does not comprise a DNA polymerase activity, wherein the ligating also forms a plurality of incomplete products, wherein the incomplete products comprise adapter-target molecules, and wherein the exonuclease selectively degrades adapter-target molecules and second sample-specific universal adapters present in the second solution not ligated to a target fragment.

23. The method of claim 22 , further comprising blocking 3′ ends of the first and second pluralities of adapter-target-adapter molecules.

24. The method of claim 23 , wherein the blocking comprises enzymatically incorporating a dideoxynucleotide onto the 3′ ends of the first and second pluralities of adapter-target-adapter molecules and the 3′ ends of the first and second sample-specific universal adapters that are not attached to a target fragment.

25. The method of claim 22 , further comprising:

providing a surface comprising a plurality of amplification sites, wherein the amplification sites comprise at least two populations of attached single stranded nuclei acids having a free 3′ end, and

contacting the surface comprising amplification sites with a mixture of the first and second pluralities of adapter-target-adapter molecules under conditions suitable to produce a plurality of amplification sites that each comprise a clonal population of amplicons from an individual adapter-target-adapter molecule.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2019
From: CHESNEY, MICHAEL; SMITH, VINCENT PETER; BEVIS-MOTT, CLAIRE; BOUTELL, JONATHAN MARK; KALBANDE, ANGELA
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 048072/0194 →
Continuity (2)
Provisional Application 62488825 · Apr 23, 2017
Related Publication 20180305753A1 · Oct 25, 2018